2型糖尿病糖耐量试验中血管内皮细胞生长因子动态观察

doi:10.3969/j.issn.1673-8640.2013.07.004

检验医学 ›› 2013, Vol. 28 ›› Issue (7): 577-580.DOI: 10.3969/j.issn.1673-8640.2013.07.004

2型糖尿病糖耐量试验中血管内皮细胞生长因子动态观察

张力, 葛才保, 黄中伟

溧水区人民医院检验科,江苏南京 211200

收稿日期:2013-07-29 修回日期:2013-07-29 出版日期:2013-07-25 发布日期:2013-07-29
作者简介:张力,男,1979年生,学士,主管技师,主要从事生物化学检验工作。

The dynamic observation of vascular endothelial growth factor in type 2 diabetes mellitus patients during glucose tolerance test

ZHANG Li,GE Caibao,HUANG Zhongwei

Department of Clinical Laboratory, the Lishui People′s Hospital , Jiangsu Nanjing 211200,China

Received:2013-07-29 Revised:2013-07-29 Online:2013-07-25 Published:2013-07-29

摘要/Abstract

摘要： 目的研究2型糖尿病(T2DM)患者口服葡萄糖(GLU)耐量试验(OGTT)中血管内皮生长因子(VEGF)的动态变化。方法测定T2DM患者接受OGTT不同时间点的GLU、胰岛素(INS)、VEGF浓度,分析T2DM组、健康对照组VEGF、INS的分泌规律。结果对照组OGTT各时间点VEGF 分泌无明显变化(P>0.05)。 T2DM组VEGF 30、60和120 min值较空腹值下降(P<0.05或0.01),180 min值与空腹值无明显差异(P>0.05)。T2DM组INS 30、60、120和180 min值都较空腹值有明显差异(P<0.05)。对照组INS最高值高于T2DM组(P<0.05)。结论 T2DM存在胰腺β细胞、VEGF分泌细胞等多种细胞功能缺陷。

关键词: 血管内皮生长因子, 胰岛素, 细胞功能, 2型糖尿病

Abstract: Objective To study the dynamic change of vascular endothelial growth factor (VEGF) in type 2 diabetes mellitus (T2DM) patients during oral glucose (GLU) tolerance test(OGTT). Methods OGTT was performed in T2DM patients and healthy controls. The GLU, insulin (INS), VEGF concentrations in different times were determined. The secretion regularity of VEGF and INS was analyzed. Results VEGF secretion did not change significantly in control group for OGTT(P>0.05). The VEGF in T2DM group at 30, 60 and 120 min decreased more significantly comparing to the VEGF at fasting (P<0.05 or 0.01). The VEGF at 180 min and fasting had no significant difference (P>0.05). The INS at 30, 60, 120 and 180 min in T2DM group had significant difference with that at fasting (P<0.05). The highest value of INS in control group was higher than that in T2DM group (P<0.05). Conclusions The cell disfunction of beta cells, VEGF-secreting cells and other cells exists in T2DM.

Key words: Vascular endothelial growth factor, Insulin, Cell function, Type 2 diabetes mellitus

中图分类号:

R446.62

张力, 葛才保, 黄中伟. 2型糖尿病糖耐量试验中血管内皮细胞生长因子动态观察[J]. 检验医学, 2013, 28(7): 577-580.

ZHANG Li,GE Caibao,HUANG Zhongwei. The dynamic observation of vascular endothelial growth factor in type 2 diabetes mellitus patients during glucose tolerance test[J]. , 2013, 28(7): 577-580.

参考文献

[1] DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009[J]. Diabetologia, 2010, 53(7): 1270-1287.

[2] 祁玥,郑亚宁.血管内皮生长因子的研究进展[J]. 青海师范大学学报(自然科学版),2010,31(4):61-66.

[3] 蔡应娱,李伟毅.血管内皮生长因子(VEGF)的生物活性及其在临床中的应用[J].细胞与分子免疫学杂志,2010,26(11):1164-1166.

[4] Long J, Wang Y, Wang W, et al. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions[J]. J Biol Chem, 2010, 285(30): 23457-23465.

[5] 易茜璐,于明香. 糖尿病视网膜病变的发病机制[J]. 复旦学报(医学版),2010,37(5):604-607.

[6] Tura A, Pacini G, Kautzky-Willer A, et al. Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders[J]. Am J Physiol Endocrinol Metab, 2003, 285(1): E155-E162.

[7] Dunning BE, Gerich JE. The role of alpha-cell dys-regulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications[J]. Endocr Rev,2007,28(3):253-283.

[8] 葛才保. 以细胞膜转运理论分析2型糖尿病发病机理[J]. 实用糖尿病杂志,2011,19(4):11-13.

[9] 葛才保,陈六生,张力.细胞外三磷酸腺苷在细胞膜物质转运中的作用机制与2型糖尿病和肿瘤的病因研究[J]. 国际检验医学杂志,2010,31(1):75-76.

[10] Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease[J]. Nat Rev Immunol, 2011, 11(2): 85-97.

[11] Jing G, Wang JJ, Zhang SX. ER stress and apoptosis: a new mechanism for retinal cell death[J]. Exp Diabetes Res, 2012, 2012:589589.

[12] Aspriello SD, Zizzi A, Lucarini G, et al. Vascular endothelial growth factor and microvessel density in periodontitis patients with and without diabetes[J]. J Periodontol, 2009, 80(11):1783-1789.

[13] Newsholme P, Homem De Bittencourt PI, O′Hagan C, et al. Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide[J]. Clin Sci (Lond), 2009, 118(5):341-349.

[14] Sun K, Wernstedt Asterholm I, Kusminski CM, et al. Dichotomous effects of VEGF-A on adipose tissue dysfunction[J]. Proc Natl Acad Sci USA, 2012, 109(15):5874-5879.

[15] Elshal MF, Kumosani TA, Abulnaja KO, et al. Influence of defatted flaxseed diet on insulin sensitivity, vascular permeability and lipid profile in a rat model of type 2 diabetes mellitus[J]. Journal of Medicinal Plants Research, 2012, 6(11):2188-2193.

[16] 宋卫东,邱太彬,王光耀,等.高糖培养对雪旺细胞增殖及血管内皮细胞生长因子分泌的影响[J].实用医学杂志,2011,27(13):2325-2326.

[17] Hagberg CE, Falkevall A, Wang X, et al. Vascular endothelial growth factor B controls endothelial fatty acid uptake[J]. Nature, 2010, 464(7290): 917-921.

2型糖尿病糖耐量试验中血管内皮细胞生长因子动态观察

The dynamic observation of vascular endothelial growth factor in type 2 diabetes mellitus patients during glucose tolerance test

RichHTML

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	梁焯辉, 赵凡, 刘倩雯. 巨噬细胞移动抑制因子与老年2型糖尿病患者颈动脉血管钙化的关系[J]. 检验医学, 2023, 38(5): 460-465.
[2]	邓旭, 庄文龙, 薛慧, 朱淑芹, 李颖. 中性粒细胞/淋巴细胞比值、纤维蛋白原与2型糖尿病患者颈动脉内中膜厚度的关系[J]. 检验医学, 2023, 38(4): 368-372.
[3]	孙文苑, 王攀, 崔丽艳. 棕色脂肪组织在改善胰岛素抵抗中的作用研究进展[J]. 检验医学, 2023, 38(3): 297-300.
[4]	吴颖, 张立红, 高吟. HDL-C对T2DM患者缺血性脑卒中发病风险的预测价值[J]. 检验医学, 2023, 38(11): 1052-1056.
[5]	张濛, 李莎, 常艳丽, 王鲁, 徐建军, 张青云. 血管内皮生长因子在黑色素瘤疗效监测和预后判断中的价值[J]. 检验医学, 2022, 37(9): 821-825.
[6]	张城, 费春霞, 付琳, 高辰飞, 倪冬英. 糖尿病足患者FGF-2、Lp-PLA2及IGF-1水平与病情的相关性分析[J]. 检验医学, 2022, 37(9): 826-830.
[7]	张嘉丰, 李丽, 李江燕, 吴洪坤, 周琳. 血小板异常升高诊断POEMS综合征1例报道[J]. 检验医学, 2022, 37(11): 1106-1108.
[8]	区苑清, 赵凡, 叶爱莲, 李立峰, 赵海桃, 黎惠贞, 梁焯辉, 李粮. 血浆网膜素1水平与2型糖尿病患者代谢清除率的关系[J]. 检验医学, 2022, 37(1): 28-31.
[9]	张馨月, 陈亮, 郑宇. 血清C肽和胰岛素样生长因子结合蛋白3与乳腺癌患者死亡风险相关性分析[J]. 检验医学, 2022, 37(1): 36-40.
[10]	刘阳, 刘柳, 丁雄英, 史昕, 周春欢, 曹政媛. 胰岛素自身抗体阴性外源性胰岛素抗体综合征1例报道[J]. 检验医学, 2021, 36(7): 779-781.
[11]	李斌, 赵冬, 黄蓉, 郭娟荪. 骨髓血管内皮生长因子水平在弥漫性大B细胞淋巴瘤疗效监测中的价值[J]. 检验医学, 2021, 36(5): 480-485.
[12]	许智越, 方勇, 卢亚运, 王修玉, 薛建华, 张伟英. 体检人群幽门螺杆菌感染与血糖异常的相关性研究[J]. 检验医学, 2021, 36(4): 412-416.
[13]	朱庆华, 王伟伟, 邹广慧, 董志武. 血清NGAL和Cys C联合检测在诊断2型糖尿病早期肾损伤中的价值[J]. 检验医学, 2021, 36(3): 281-284.
[14]	杨勇. SCC-Ag、CA19-9、VEGF在晚期食管鳞癌化疗疗效判断中的价值[J]. 检验医学, 2021, 36(1): 20-24.
[15]	张前进, 胡金娥, 胡一川, 丁颖, 沈艳秋, 陈慧芹. 血清降脂素及维生素D与2型糖尿病患者胰岛β细胞功能及胰岛素敏感性的相关性[J]. 检验医学, 2020, 35(9): 908-911.